CSS
AMED

Cubist Systematic Strategies’s Amedisys AMED Stock Holding History

Cubist Systematic Strategies’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-8,200
Closed -$779K – 3669
2023
Q4 		$779K Sell
8,200
-10,900
-57% -$1.02M 0.01% 2241
2023
Q3 		$1.78M Hold
19,100
– – 0.01% 1444
2023
Q2 		$1.75M Buy
19,100
+14,600
+324% +$1.2M 0.01% 1587
2023
Q1 		$331K Buy
4,500
+800
+22% +$69.2K ﹤0.01% 2919
2022
Q4 		$309K Buy
+3,700
New +$334K ﹤0.01% 3340

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Cubist Systematic Strategies's AMED Position: Q3 2025 in Review

Cubist Systematic Strategies sold out of Amedisys (AMED) in Q3 2025, closing a stake of 6,291 shares — an estimated $619K sold.

Cubist Systematic Strategies first reported a position in AMED in Q3 2014 and held it in 32 quarters. The position peaked at $12.7M in Q3 2021. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Cubist Systematic Strategies reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Cubist Systematic Strategies sold 6,291 Amedisys shares in Q3 2025, an estimated $619K.
  • Cubist Systematic Strategies first reported a position in Amedisys in Q3 2014 and held it in 32 quarters.
  • Cubist Systematic Strategies's Amedisys position peaked at $12.7M in Q3 2021.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.